Federal grants to Abvacc, Inc.
Abvacc, Inc. in Rockville, Maryland received $16.1 million in federal grants from fiscal 2021 to 2025, across 10 awards. Its largest program was Allergy and Infectious Diseases Research, with $16.1 million. In fiscal 2025 it was awarded $3.5 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$16.1 million
- Awards10
- Awarded in FY 2025$3.5 million
- Largest award$3.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 5 | $1.2 million |
| FY 2022 | 4 | $5.5 million |
| FY 2023 | 5 | $3.7 million |
| FY 2024 | 4 | $2.3 million |
| FY 2025 | 5 | $3.5 million |
Programs that fund Abvacc, Inc.
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 10 | $16.1 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 10 | $16.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Immunotherapy of mrsa osteomyelitis - methicillin-resistant staphylococcus aureus (MRSA) causes invasive infections in about 80,000 americans every year with a 14% overall mortality rate, despite the availability of drugs that are active against mrsa. In addition, a significant number of invasive di | Allergy and Infectious Diseases Research | May 11, 2021 | $3.0 million |
| Prophylactic immunotherapy for marburg virus disease outbreak control - the ebolaviruses (ebov, sudv, bdbv) and marburgviruses (marv and ravv), cause periodic outbreaks of severe viral hemorrhagic fever with very high mortality rates. The 2013-2016 ebola virus disease (EVD) outbreak in west africa h | Allergy and Infectious Diseases Research | May 12, 2023 | $2.8 million |
| Protective versus deleterious immune responses that impact vaccine efficacy against staphylococcus aureus bloodstream infection | Allergy and Infectious Diseases Research | February 23, 2021 | $2.8 million |
| Development of a universal immunotherapeutic for influenza viruses | Allergy and Infectious Diseases Research | April 8, 2021 | $1.5 million |
| Multivalent toxoid vaccine for prevention of s. Aureus invasive diseases | Allergy and Infectious Diseases Research | July 6, 2021 | $1.5 million |
| Monoclonal antibody cocktail for treatment of marburg virus disease - project summary ebola (EBOV) and marburg (MARV) viruses cause hemorrhagic fever disease in humans and nonhuman primates (NHPS) with case-fatality rates as high as 90%. The 2013-2016 ebola virus disease (EVD) outbreak led to over 2 | Allergy and Infectious Diseases Research | August 11, 2023 | $1.3 million |
| Rationally designed pan-ebolavirus vaccine | Allergy and Infectious Diseases Research | May 26, 2021 | $1.1 million |
| Infection site targeted antitoxin antibody (ISTAB) against bacillus anthracis | Allergy and Infectious Diseases Research | June 11, 2021 | $977,301 |
| A multimodal approach for immunotherapy of staphylococcus aureus bacteremia - staphylococcus aureus (s. Aureus; sa) colonizes >50% of people and causes a wide range of diseases including bacteremia, pneumonia, and surgical site infections. No sa vaccines or immunotherapeutics are approved or in late | Allergy and Infectious Diseases Research | August 22, 2025 | $638,953 |
| Development of a marburgvirus subunit vaccineadjuvanted with a novel TLR7/TLR8 agonist - there is an outbreak of marburg virus disease (MVD), relative of ebola virus, currently ongoing in equatorial guinea and tanzania. There have been multiple, deadly outbreaks of mvd in the past with ~88% lethalit | Allergy and Infectious Diseases Research | February 26, 2024 | $596,627 |
Questions people ask
How much federal grant money does Abvacc, Inc. get?
$16.1 million in 10 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Abvacc, Inc. the most?
The Department of Health and Human Services, with $16.1 million in 10 awards.
What is Abvacc, Inc.'s largest federal grant?
$3.0 million under Allergy and Infectious Diseases Research, with its first action in the period on May 11, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Other grant recipients in Rockville
- X Energy, LLC
- Abt Global LLC
- Westat, Inc.
- The United States Pharmacopeial Convention, Inc.
- Montgomery College
- JBS International, Inc.
- Child Trends, Incorporated
- Sanaria Inc.
Largest federal grant recipients in Maryland · Federal grants in Maryland